NPM1 and myeloid sarcoma: NPM1 immunohistochemistry revealed aberrant cytoplasmic signal (Figure 1F, original magnification 500×, inset original magnification 1000×), confirming the diagnosis of NPM1‐mutant myeloid sarcoma.